Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study

Journal of Investigative Dermatology

Volumn 128, Issue 1, 2008, Pages 35-44

  Mockenhaupt, Maja ^a,i   Viboud, Cecile ^b   Dunant, Ariane ^c,h   Naldi, Luigi ^d   Halevy, Sima ^e   Bavinck, Jan Nico Bouwes ^f   Sidoroff, Alexis ^g   Schneck, Jürgen ^a   Roujeau, Jean Claude ^h   Flahault, Antoine ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b INSERM   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d OSPEDALI RIUNITI   (Italy)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ Dokumentationszentrum Schwerer Hautreaktionen DZh   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMINOPENICILLIN; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; CYCLOOXYGENASE 2 INHIBITOR; FLUCONAZOLE; FLUOXETINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMOTRIGINE; LEFLUNOMIDE; MACROLIDE; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PANTOPRAZOLE; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; PROTON PUMP INHIBITOR; PYRAZOLONE DERIVATIVE; QUINOLONE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULFONAMIDE; TERBINAFINE; TETRACYCLINE DERIVATIVE; TRAMADOL; UNINDEXED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG MARKETING; FEMALE; GENDER; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STEVENS JOHNSON SYNDROME; TIME SERIES ANALYSIS; TOXIC EPIDERMAL NECROLYSIS; VALIDATION PROCESS;

EID: 37049020666     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701033     Document Type: Article

References (24)

1. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138:1019-24
2. Barreiro P, Soriano V, Casas E, Estrada V, Tellez M, Hoetelmans R et al. (2000) Prevention of Nevirapine-associated exanthema using slow dose escalation and/or corticosteroids. AIDS 14:2153-7
3. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau J-C (1993) A clinical classification of cases of toxic epidermal necrolysis, Stevens - Johnson syndrome and erythema multiforme. Arch Dermatol 129:92-6
4. Becker DS (1998) Toxic epidermal necrolysis. Lancet 351:1417-20
5. Bodokh I, Lacour JP, Rosenthal E, Chichmanian RM, Perrin C, Vitetta A et al. (1992) Lyell syndrome or toxic epidermal necrolysis and Stevens-Johnson syndrome after treatment with fluoxetine. Therapie 47:441
6. Cars O, Mostad S, Melander A (2001) Variation in antibiotic use in the European Union. Lancet 357:1851-3
7. Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau J-C (2001) Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis: preliminary results of a case-control study. AIDS 15:1-6
8. Fischer TW, Bauer HI, Graefe T, Barta U, Elsner P (2003) Erythema multiforme-like drug eruption with oral involvement after intake of leflunomide. Dermatology 207:386-9
9. Friedman B, Orlet HK, Still JM, Law E (2003) Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). South Med J 96:1213-4 (comment in: South Med J. 96:320-321).
10. GISED (1993) Cutaneous reactions to analgesic-antipyretics and non-steroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia. Dermatology 186:164-9
11. Gussenhoven MJE, Haak A, Peereboom-Wynia JDR (1991) Stevens-Johnson syndrome after fluconazole. Lancet 338:120
12. Jan V, Toledano C, Machet L, Machet MC, Vaillant L, Lorette G (1999) Stevens-Johnson syndrome after sertraline. Acta Derm Venereol 79:401
13. Kelly JP, Auquier A, Rzany B, Naldi L, Bastuji-Garin S, Correia O et al. (1995) An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol 48:1099-108
14. Mockenhaupt M, Kelly JP, Kaufman D, Stern RS (2003) The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with non-steroidal antiinflammatory drugs: a multinational perspective. J Rheumatol 30:2234-40
15. Mockenhaupt M, Messenheimer J, Schlingmann J, Tennis P (2005) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of anti-epileptics. Neurology 64:1134-8
16. Pfeiffer CM, Kazenoff S, Rothberg HD (1998) Toxic epidermal necrolysis from atorvastatin. JAMA 279:1613-4
17. Roujeau J-C, Stern RS (1994) Severe cutaneous adverse reactions to drugs. N Engl J Med 331:1272-85
18. Roujeau J-C, Kelly JP, Naldi L, Rzany B, Stern S, Anderson T et al. (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600-7
19. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R (1999) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of anti-epileptic therapy: a case-control study. Lancet 353:2190-4
20. Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J et al. (1996) Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990-1992). Structure and results of a population based registry. J Clin Epidemiol 49:769-73
21. Rzany B, Mockenhaupt M, Gehring W, Schöpf E (1994) Stevens-Johnson syndrome after terbinafine therapy. J Am Acad Dermatol 30:509
22. Sachs B, Ronnau AC, Ruzicka T, Gleichmann E, Schuppe HC (1996) Lamotrigine and toxic epidermal necrolysis. Lancet 348:1041
23. Slone D, Shapiro S, Miettinen O (1977) Case control surveillance of serious illnesses attributable to ambulatory use of drugs. In: Epidemiological Evaluation of Drugs. (Colombo F, Slone D, Shapiro S, Tognoni G, eds) Amsterdam: Elsevier North Holland Biomedical Press
24. Warren KJ, Boxwell DE, Kim NY, Drolet BA (1998) Nevirapine-associated Stevens-Johnson syndrome. Lancet 351:567